Selective Inactivation of Socs3 in SF1 Neurons Improves Glucose Homeostasis without Affecting Body Weight
Tóm tắt
Suppressor of cytokine signaling 3 (Socs3) has been identified as a mediator of central leptin resistance, but the identity of specific neurons in which Socs3 acts to suppress leptin signaling remains elusive. The ventromedial hypothalamus (VMH) was recently shown to be an important site for leptin action because deleting leptin receptor within VMH neurons causes obesity. To examine the role of VMH Socs3 in leptin resistance and energy homeostasis, we generated mice lacking Socs3 specifically in neurons positive for steroidogenic factor 1 (SF1), which is expressed abundantly in the VMH. These mice had increased phosphorylation of signal transducer and activator of transcription-3 in VMH neurons, suggesting improved leptin signaling, and consistently, food intake and weight-reducing effects of exogenous leptin were enhanced. Furthermore, on either chow or high-fat diets, these mice had reduced food intake. Unexpectedly, energy expenditure was reduced as well. Mice lacking Socs3 in SF1 neurons, despite no change in body weight, had improved glucose homeostasis and were partially protected from hyperglycemia and hyperinsulinemia induced by high-fat diets. These results suggest that Socs3 in SF1 neurons negatively regulates leptin signaling and plays important roles in mediating leptin sensitivity, glucose homeostasis, and energy expenditure.
Từ khóa
Tài liệu tham khảo
Zhang, 1994, Positional cloning of the mouse obese gene and its human homologue., Nature, 372, 425, 10.1038/372425a0
Halaas, 1995, Weight-reducing effects of the plasma protein encoded by the obese gene., Science, 269, 543, 10.1126/science.7624777
Pelleymounter, 1995, Effects of the obese gene product on body weight regulation in ob/ob mice., Science, 269, 540, 10.1126/science.7624776
Campfield, 1995, Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks., Science, 269, 546, 10.1126/science.7624778
Farooqi, 1999, Effects of recombinant leptin therapy in a child with congenital leptin deficiency., N Engl J Med, 341, 879, 10.1056/NEJM199909163411204
Montague, 1997, Congenital leptin deficiency is associated with severe early-onset obesity in humans., Nature, 387, 903, 10.1038/43185
Halaas, 1997, Physiological response to long-term peripheral and central leptin infusion in lean and obese mice., Proc Natl Acad Sci USA, 94, 8878, 10.1073/pnas.94.16.8878
Lowell, 2000, Toward a molecular understanding of adaptive thermogenesis., Nature, 404, 652, 10.1038/35007527
Maffei, 1995, Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects., Nat Med, 1, 1155, 10.1038/nm1195-1155
Frederich, 1995, Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action., Nat Med, 1, 1311, 10.1038/nm1295-1311
Considine, 1996, Serum immunoreactive-leptin concentrations in normal-weight and obese humans., N Engl J Med, 334, 292, 10.1056/NEJM199602013340503
Heymsfield, 1999, Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial., JAMA, 282, 1568, 10.1001/jama.282.16.1568
Schwartz, 1996, Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans., Nat Med, 2, 589, 10.1038/nm0596-589
Carpenter, 1998, Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor., Proc Natl Acad Sci USA, 95, 6061, 10.1073/pnas.95.11.6061
Elchebly, 1999, Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene., Science, 283, 1544, 10.1126/science.283.5407.1544
Zabolotny, 2002, PTP1B regulates leptin signal transduction in vivo., Dev Cell, 2, 489, 10.1016/S1534-5807(02)00148-X
Cheng, 2002, Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B., Dev Cell, 2, 497, 10.1016/S1534-5807(02)00149-1
Bjorbaek, 1998, Identification of SOCS-3 as a potential mediator of central leptin resistance., Mol Cell, 1, 619, 10.1016/S1097-2765(00)80062-3
Caro, 1996, Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance., Lancet, 348, 159, 10.1016/S0140-6736(96)03173-X
Mori, 2004, Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity., Nat Med, 10, 739, 10.1038/nm1071
Howard, 2004, Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3., Nat Med, 10, 734, 10.1038/nm1072
Kievit, 2006, Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells., Cell Metab, 4, 123, 10.1016/j.cmet.2006.06.010
Balthasar, 2005, Divergence of melanocortin pathways in the control of food intake and energy expenditure., Cell, 123, 493, 10.1016/j.cell.2005.08.035
Hetherington, 1940, Hypothalamic lesions and adiposity in the rat., Anat Rec, 78, 149, 10.1002/ar.1090780203
Elmquist, 1998, Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei., Proc Natl Acad Sci USA, 95, 741, 10.1073/pnas.95.2.741
Dellovade, 2000, Disruption of the gene encoding SF-1 alters the distribution of hypothalamic neuronal phenotypes., J Comp Neurol, 423, 579, 10.1002/1096-9861(20000807)423:4<579::AID-CNE4>3.0.CO;2-#
Dhillon, 2006, Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis., Neuron, 49, 191, 10.1016/j.neuron.2005.12.021
Bingham, 2008, Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome., Endocrinology, 149, 2138, 10.1210/en.2007-1200
Yasukawa, 2003, IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages., Nat Immunol, 4, 551, 10.1038/ni938
Munzberg, 2003, Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin., Endocrinology, 144, 2121, 10.1210/en.2002-221037
Elias, 1999, Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area., Neuron, 23, 775, 10.1016/S0896-6273(01)80035-0
Mantzoros, 2000, Editorial: leptin as a therapeutic agent—trials and tribulations., J Clin Endocrinol Metab, 85, 4000
Hukshorn, 2000, Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men., J Clin Endocrinol Metab, 85, 4003, 10.1210/jcem.85.11.6955
Flier, 2004, Obesity wars: molecular progress confronts an expanding epidemic., Cell, 116, 337, 10.1016/S0092-8674(03)01081-X
Friedman, 1998, Leptin and the regulation of body weight in mammals., Nature, 395, 763, 10.1038/27376
Spiegelman, 1996, Adipogenesis and obesity: rounding out the big picture., Cell, 87, 377, 10.1016/S0092-8674(00)81359-8
Morton, 2006, Central nervous system control of food intake and body weight., Nature, 443, 289, 10.1038/nature05026
El-Haschimi, 2000, Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity., J Clin Invest, 105, 1827, 10.1172/JCI9842
Stallings, 2002, Development of a transgenic green fluorescent protein lineage marker for steroidogenic factor 1., Mol Endocrinol, 16, 2360, 10.1210/me.2002-0003
Pocai, 2005, Central leptin acutely reverses diet-induced hepatic insulin resistance., Diabetes, 54, 3182, 10.2337/diabetes.54.11.3182
Shi, 2004, Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling., J Biol Chem, 279, 34733, 10.1074/jbc.M403886200
Senn, 2003, Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes., J Biol Chem, 278, 13740, 10.1074/jbc.M210689200
Ueki, 2004, Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms., Mol Cell Biol, 24, 5434, 10.1128/MCB.24.12.5434-5446.2004
Obici, 2002, Hypothalamic insulin signaling is required for inhibition of glucose production., Nat Med, 8, 1376, 10.1038/nm1202-798